Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

More Inhalers Changes

Two further changes have been announced that will affect the availability of some inhaler devices used in the treatment of asthma.

Firstly, Nedocromil (Tilade) inhalers are being replaced with a CFC-Free version with immediate effect. Patients should be advised to clean this new device as per the patient information leaflet to avoid blockages.

Secondly, the CFC containing inhaler, Sodium Cromoglicate (Intal) will be discontinued. This appears to only affect the Intal brand with no indication if the other Sodium Cromoglicate containing products (e.g. Cromogen) will also be affected.

Changes in propellant are likely to affect the sound and taste experienced by the patient. Patients should be warned to expect these changes so their confidence in the treatment is not affected.

Action: Clinicians who treat respiratory disease should be aware of the on going changes in asthma devices. Information about the changes in inhalers should be provided at the point of prescribing and dispensing.

Share 'More Inhalers Changes' on Email Share 'More Inhalers Changes' on Delicious Share 'More Inhalers Changes' on Digg Share 'More Inhalers Changes' on Facebook Share 'More Inhalers Changes' on Google+ Share 'More Inhalers Changes' on reddit Share 'More Inhalers Changes' on StumbleUpon Share 'More Inhalers Changes' on Twitter

atomic-wealth

No Comments to “More Inhalers Changes”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,431 spam comments.

atomic-wealth
fond-illness
summer